Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80
Organisation › Details

Biognosys AG

Biognosys is a leader in next-generation proteomics, dedicated to transforming life science research by developing the most advanced proteomics tools and making them available for pharmaceutical and biotech research and development. The company offers a suite of products and services to decode the proteome and equip researchers from all fields with a deep view of protein expression and regulation in cells, tissues, or body fluids. Biognosys’ technology is based on high-resolution mass spectrometry, combined with a novel parallel signal processing approach, for unprecedented quantification of large proteomes in a single experiment. *

 

Period Start 2008-09-09 splitoff
  Predecessor ETH Zürich (ETHZ)
Products Industry proteomics
  Industry 2 multiple reaction monitoring (MRM) technology
Persons Person Rinner, Oliver (Biognosys 201212– CSO + founder before CEO)
  Person 2 Novak, Lidia (Biognosys 2019089 CFO)
     
Region Region Schlieren ZH
  Country Switzerland
  Street 25 Wagistr.
Bio-Technopark
  City 8952 Schlieren ZH
  Tel +41-44-738-2040
    Address record changed: 2021-04-13
     
Basic data Employees n. a.
     
    * Document for �About Section�: Biognosys AG. (6/17/20). "Press Release: Biognosys Announces Appointment of Dr. Patrick Vink as Chairman". Schlieren.
     
   
Record changed: 2021-05-20

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Biognosys AG


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture [iito] Back into Ad 650x80px




» top